Parmar Kush's Form 4 filing
Entrada Therapeutics, Inc. (TRDA) · filed Nov 18, 2025
- Accession no.
- 0001664281-25-000003
- Filed
- Nov 18, 2025
- Trade date
- Nov 14, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.76M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parmar KushCIK 0001664281 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 | Common Stock | SSaleDisposed | −200,000 | $8.80 | −$1,760,000 | 2,963,066 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.